Industry Verticals »

All Categories

Insights »

About TMR »

Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market (By Product Type: Consumables & Assays [Reagents & Kits], Instruments, Software & Services; By Disease Type; By Test Type: Antinuclear Antibody (ANA) Tests, Rheumatoid Factor (RF) Tests, Anti-CCP Tests, Autoantibody Tests, C-reactive Protein (CRP) Tests, Erythrocyte Sedimentation Rate (ESR) Tests, Complete Blood Count (CBC), Comprehensive Metabolic Panel, Urinalysis, Others; and by End-user) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026-2036

Autoimmune Disease Diagnostics Market Outlook 2036

The global autoimmune disease diagnostics market size was valued at USD 5.9 Billion in 2025 and is projected to reach USD 14.9 Billion by 2036, expanding at a CAGR of 8.8% from 2026 to 2036. The market experiences continuous growth because more people are diagnosed with autoimmune disorders which include rheumatoid arthritis and lupus and thyroid diseases. The market expansion receives additional support from increased public knowledge and better diagnostic methods which include antibody testing and automated systems. The growing healthcare facilities in developing areas will create future demand for healthcare services.

Market Size & Highlights

  • The autoimmune disease diagnostics market reached USD 5.9 Billion in 2025.
  • The market is estimated to reach USD 14.9 Billion by 2036
  • The autoimmune disease diagnostics industry is anticipated to expand at a CAGR of 8.8 % from 2026 to 2036.
  • Top companies in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc.
  • North America dominated the market in 2025, holding the largest revenue share of 34.7%
  • By test type, the antinuclear antibody tests segment held major market share of 33.2% in 2025

Autoimmune Disease Diagnostics Market By Revenue

Analysts’ Viewpoint

The autoimmune disease diagnostics market is expected to experience consistent growth during the forecast period because of rising autoimmune disorder cases and the need for improved diagnostic methods which provide both quick and precise test results. Patients and healthcare providers have become more aware of testing procedures resulting in increased testing for rheumatoid arthritis systemic lupus erythematosus and thyroid-related disorders. The development of diagnostic technologies has created better autoantibody detection methods and automated immunoassay systems which improve testing efficiency and result accuracy.

The market maintains substantial market share through reagents and assay kits because customers use these products repeatedly for diagnostic tests. The market sees growing interest in instruments and software because laboratories move toward automated testing systems. Developed markets, including North America and Europe, maintain their leading position because of their established healthcare systems which support advanced diagnostic technology. The Asian Pacific region shows potential for growth as emerging economies increase their healthcare spending while more people gain access to medical testing facilities.

The healthcare market shows positive growth patterns but faces challenges because advanced diagnostic tests carry high costs and low-resource areas lack test availability. The market will experience expansion through three factors which include ongoing research efforts and technological breakthroughs and the growth of healthcare facilities. The market outlook demonstrates positive trends because diagnostic systems keep improving and healthcare systems require better methods to handle diseases.

Market Introduction

The autoimmune disease diagnostics market focuses on tests and technologies used to identify conditions in which the body’s immune system mistakenly attacks its own cells and tissues. The diseases show various symptoms which require doctors to make precise diagnoses at an early stage to ensure they deliver correct treatment. Rheumatoid arthritis and lupus and multiple sclerosis and thyroid-related disorders such as Graves' disease and Hashimoto's thyroiditis stand as some of the most frequently diagnosed autoimmune diseases.

The market has experienced steady growth because the number of autoimmune cases continues to increase throughout the world. The population exhibits higher diagnostic rates because of three primary factors which include lifestyle changes and genetic factors and increased public awareness. Healthcare professionals now have better tools to identify these diseases through improvements in diagnostic technologies which include enhanced antibody testing and automated laboratory systems.

The market mainly includes products such as reagents and kits and instruments and supporting software which help users to operate diagnostic tests and perform their analysis. Hospitals and diagnostic laboratories are the primary users of these products because they conduct extensive patient testing procedures. The developed regions of North America and Europe hold the current market leading position because they possess advanced healthcare systems, while Asia Pacific is expected to experience faster market expansion through increased healthcare spending and public awareness.

The autoimmune disease diagnostics market helps to improve patient outcomes through its diagnostic solutions which enable medical professionals to conduct early disease detection and ongoing patient monitoring. The market will experience further expansion because ongoing research efforts and new testing technologies will continue to emerge.

Attribute Detail
Market Drivers
  • Rising Prevalence of Autoimmune Diseases
  • Growing Demand for Early and Accurate Diagnosis

Rising Prevalence of Autoimmune Diseases

The autoimmune disease diagnostics market expands because more people develop autoimmune diseases which creates a need for precise testing that can identify their condition at an early stage. The National Institutes of Health report that autoimmune diseases impact almost 8% of the United States population which creates a major and increasing health crisis. The Centers for Disease Control and Prevention report that millions of people in the United States experience chronic autoimmune diseases which lead to continuous medical care and multiple diagnostic assessments.

In 2023, large-scale epidemiological study shows that 4.6% of the U.S. population has been diagnosed with at least one autoimmune disease which leads many patients to develop multiple autoimmune disorders. The National Library of Medicine states that about 30% of patients will develop additional autoimmune disorders which makes their diagnosis more difficult because it requires complete testing panels. Autoimmune diseases show a higher incidence in women because they make up about 75 to 80% of total cases which creates a need for ongoing diagnostic assessment of this specific patient group.

The global incidence of autoimmune diseases shows an annual growth rate between 3% and 12% according to research conducted by government-supported institutions. The ongoing increase arises from multiple factors which include environmental shifts and hereditary vulnerability and better disease identification methods. The number of people who require diagnostic tests will rise because these diseases demand permanent tracking, which drives up the need for tests that include autoantibody assessments and inflammatory marker evaluations and standard blood work. The autoimmune disease diagnostics market will experience continuous growth during the next several years because of this market trend.

Growing Demand for Early and Accurate Diagnosis

The increasing need for precise and timely disease identification drives market growth for autoimmune disorder testing because delayed diagnosis leads to worse patient outcomes and higher healthcare system costs. The Indian Rheumatology Association reports that median diagnostic time for systemic lupus erythematosus (SLE) reaches 6 months while only 30.7% of patients obtain their diagnosis within 3 months showing major deficiencies in early detection. Studies available in government-supported medical databases demonstrate that lupus diagnostic processes experience delays which can exceed 2 years resulting in higher rates of organ damage and medical complications.

Clinical research demonstrates the need for early diagnosis because medical professionals need prompt detection to start medical intervention during crucial health periods. According to findings referenced in rheumatology research starting treatment within the first 12 weeks of indication onset results in better long-term outcomes while decreasing disease progression. The research shows that delayed diagnosis leads to higher disease severity and lower patient quality of life because patients experience extended periods of untreated inflammation.

Autoimmune diseases show non-specific symptoms which make it vital to create accurate diagnostic tools that help medical staff identify diseases at their earliest stages. The healthcare field experiences increased disease identification through two factors which include rising healthcare provider knowledge and better biomarker testing methods. The market now demands advanced diagnostic technologies which enable improved disease identification in patients.

Attribute Detail
Market Opportunities
  • Advancements in Multiplex and Point-of-Care Testing Creating New Growth Opportunities

Advancements in Multiplex and Point-of-Care Testing Creating New Growth Opportunities

The development of multiplex and point-of-care (POC) testing solutions will create market potential within the autoimmune disease diagnostics sector because healthcare providers require diagnostic tools that deliver results at lower costs and through decentralized methods. The World Health Organization reports that 70% of medical decisions depend on diagnostic results which receive only 3% to 5% of worldwide healthcare funding, thus creating an opportunity to develop more effective testing methods.

The rising significance of multiplex diagnostics enables multiple biomarker testing from a single sample for disease assessment in autoimmune disorders which need multiple validation tests. The Centers for Disease Control and Prevention report that multiplex molecular tests achieve quicker diagnosis and treatment times than standard laboratory methods because they provide efficient results for medical facilities.

Global health organizations are working to establish integrated testing systems that utilize multiplex testing methods as a means to boost healthcare operational efficiency. The World Health Organization states that multiplex platforms deliver better diagnostic results at lower costs in areas that lack access to multiple testing systems.

Diagnostic testing at patient locations benefits from point-of-care testing which produces results within minutes instead of requiring hours or days to complete traditional testing procedures. This system proves extremely beneficial for patients who need ongoing assessment of their chronic autoimmune disease.

Antinuclear Antibody (ANA) Tests Dominating Global Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market By Type

Among the test types, the autoimmune disease diagnostic market utilizes Antinuclear Antibody (ANA) tests as its most common diagnostic tool which doctors use to evaluate multiple autoimmune diseases. Medical professionals use these tests as their initial diagnostic method to identify systemic lupus erythematosus and rheumatoid arthritis and other connective tissue disorders. The National Library of Medicine reports that ANA testing serves as a fundamental diagnostic tool which doctors use to identify various autoimmune diseases.

The segment maintains its leading position because of the extensive testing activities which take place throughout the world. The Government of British Columbia health guidelines report that more than 114000 ANA tests occurred during the 2022-2023 period which showed common usage despite the region's low rates of connective tissue diseases. The usage of ANA testing occurs in medical practice to establish both diagnosis and preliminary assessment of patients who show signs of autoimmune diseases.

Regional Outlook of Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market By Region

Attribute Detail
Leading Region
  • North America

North America dominates the Autoimmune Disease Diagnostics market by 34.7% share, owing to high disease burden and strong healthcare infrastructure and medical facilities use advanced diagnostic technologies. The National Institutes of Health reports that antinuclear antibodies (ANA) autoimmune markers exist in 15.9% of the U.S. population which equals almost 41 million people and creates a substantial population base for testing. The Journal of Clinical Investigation reports that between 2011 and 2022 more than 15 million people (4.6% of the U.S. population) received autoimmune disease diagnoses and showed a 34% diagnosis rate for multiple conditions which results in an increased requirement for both standard and advanced testing procedures. The region maintains its dominant market position because of high testing rates and effective payment systems and early detection methods.

The United States represents the largest contributor within North America, driven by a high patient pool and advanced diagnostic adoption. The Centers for Disease Control and Prevention reports that approximately 204,000 people in the United States have systemic lupus erythematosus SLE which primarily affects women at a rate of 90. The Journal of Clinical Investigation reports that more than 15 million people with autoimmune diseases create a substantial need for diagnostic tests. The United States operates as the main country generating revenue in this market because its people have high awareness about advanced immunoassay systems and they can easily reach diagnostic laboratories which allow them to undergo regular screening and medical checkups.

Analysis of Key Players in Autoimmune Disease Diagnostics Market

The autoimmune disease diagnostics market shows established international companies who work on developing new technologies through their existing product lines. The companies Abbott Laboratories and F. Hoffmann-La Roche Ltd. possess integrated diagnostic platforms and immunoassay technologies which enable them to conduct high-throughput testing. Siemens Healthineers AG and Danaher Corporation develop automated laboratory systems which enable their clients to achieve faster results with increased productivity.

Thermo Fisher Scientific Inc. and Bio-Rad Laboratories Inc. generate stable income through their extensive collection of reagents and assays which they sell to customers. The National Institutes of Health reports that rising autoimmune marker and disease rates create increased need for better diagnostic methods which lead businesses to invest in artificial intelligence-based solutions and multiple testing and automation systems. The market competitiveness depends on three main factors which include product development and diagnostic precision and complete laboratory solutions.

Key Developments in Autoimmune Disease Diagnostics Market

  • On April 09, 2026, Progentec Diagnostics, Inc., a leader in precision diagnostics for autoimmune diseases, announced the publication of new research in Lupus Science & Medicine and the award of an Oklahoma Center for the Advancement of Science and Technology (OCAST) Industry Innovation Grant to further develop its lupus classification risk blood test.
  • On January 12, 2026, 10x Genomics, Inc., a leader in single cell and spatial biology, announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center, to analyze peripheral blood samples from patients living with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and giant cell arteritis (GCA) to uncover immune signatures associated with disease activity, flare, remission and therapeutic response.
  • In October 2025, Boehringer Ingelheim and Kyowa Kirin Co., Ltd. announced that Boehringer Ingelheim has licensed a pre-clinical program from Kyowa Kirin to develop a potential first-in-class, small molecule for the treatment of autoimmune diseases.
  • In February 2025, Revvity, Inc. has announced a program for expansion of its type 1 diabetes (T1D) offering to include a population-scale assay for early detection with support from Sanofi. Revvity will develop a T1D 4-plex in vitro diagnostic (IVD) assay based on its existing research-use (RUO) 3-plex assay.

Autoimmune Disease Diagnostics Market Snapshot

Attribute Detail
Size in 2025 USD 5.9 Billion
Forecast Value in 2036 USD 14.9 Billion
CAGR 8.8%
Forecast Period 2026-2036
Historical Data Available for 2021-2025
Quantitative Units USD Billion
Autoimmune Disease Diagnostics Market Analysis It includes segment analysis and regional level analysis. Qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation Product Type
  • Consumables & Assays (Reagents & Kits)
  • Instruments
  • Software & Services
Disease Type
  • Graves’ Disease
  • Hashimoto’s Thyroiditis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus (SLE)
  • Type 1 Diabetes
  • Other Autoimmune Diseases
Test Type
  • Antinuclear Antibody (ANA) Tests
  • Rheumatoid Factor (RF) Tests
  • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
  • Autoantibody Tests
  • C-reactive Protein (CRP) Tests
  • Erythrocyte Sedimentation Rate (ESR) Tests
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel
  • Urinalysis
  • Other Diagnostic Tests
End-user
  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • The Netherlands
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Brazil
  • Mexico
  • Argentina
  • GCC Countries
  • South Africa
Companies Profiled
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Beckman Coulter, Inc.
  • Grifols, S.A.
  • Hologic, Inc.
  • Ortho Clinical Diagnostics Holdings plc
  • QuidelOrtho Corporation
  • Trinity Biotech plc
  • Sekisui Diagnostics, LLC
  • Omega Diagnostics Group PLC
  • AESKU.GROUP GmbH & Co. KG
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Inova Diagnostics, Inc.
  • Werfen (Instrumentation Laboratory Company)
  • Quest Diagnostics Incorporated
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global autoimmune disease diagnostics market in 2025?

The market was valued at USD 5.9 Billion in 2025

How big will the global autoimmune disease diagnostics industry be in 2036?

The industry is projected to reach USD 14.9 Billion by 2036

What are the factors driving the autoimmune disease diagnostics market?

Rising prevalence of autoimmune diseases and increasing demand for early, accurate diagnosis are the key factors driving market growth.

What will be the CAGR of the global autoimmune disease diagnostics industry during the forecast period?

The CAGR is anticipated to be 8.8% from 2026 to 2036

Which region will account for a major share of the autoimmune disease diagnostics sector during the forecast period?

North America is expected to account for the largest share from 2026 to 2036

Who are the prominent players in the global Autoimmune disease diagnostics market?

Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., bioMérieux SA, Beckman Coulter, Inc., Grifols, S.A., Hologic, Inc., Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation, Trinity Biotech plc, Sekisui Diagnostics, LLC, Omega Diagnostics Group PLC, AESKU.GROUP GmbH & Co. KG, EUROIMMUN Medizinische Labordiagnostika AG, Inova Diagnostics, Inc., Werfen (Instrumentation Laboratory Compan

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary: Global Autoimmune Disease Diagnostics Market
  4. Market Overview
    • Introduction
      • Segment Definition
      • Industry Evolution / Developments
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Autoimmune Disease Diagnostics Market Analysis and Forecast, 2021-2036
      • Market Revenue Projections (USD Billion)
  5. Key Insights
    • Healthcare Expenditure by Country/Region
    • Recent Technological Advancements
    • Regulatory Scenario across Key Countries / Regions
    • PORTER’s Five Forces Analysis
    • Consumer Behavior & End-User Insights
    • PESTLE Analysis
    • Key Industry Events
    • Go to Marketing Strategies for New Entrants
    • Pricing Analysis
    • Distributors Landscape
  6. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Product Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Attractiveness Analysis, by Product Type
  7. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Disease Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Attractiveness Analysis, by Disease Type
  8. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Test Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Attractiveness Analysis, by Test Type
  9. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by End-user
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis, by End-user
  10. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Region
    • Key Findings
    • Market Value Forecast, by Region, 2021-2036
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • Market Attractiveness Analysis, by Region
  11. North America Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
      • By Country/Sub-region
  12. U.S. Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  13. Canada Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  14. Europe Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
      • By Country/Sub-region
  15. Germany Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  16. U.K. Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  17. France Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  18. Italy Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  19. Spain Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  20. The Netherlands Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  21. Rest of Europe Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  22. Asia Pacific Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • ASEAN
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
      • By Country/Sub-region
  23. China Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  24. India Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  25. Japan Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  26. South Korea Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  27. Australia Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  28. ASEAN Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  29. Rest of Asia Pacific Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  30. Latin America Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
      • By Country/Sub-region
  31. Brazil Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  32. Mexico Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  33. Argentina Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  34. Rest of Latin America Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  35. Middle East & Africa Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
      • By Country/Sub-region
  36. GCC Countries Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  37. South Africa Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  38. Rest of Middle East & Africa Autoimmune Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product Type , 2021-2036
      • Consumables & Assays (Reagents & Kits)
      • Instruments
      • Software and Services
    • Market Value Forecast, by Disease Type, 2021-2036
      • Graves’ Disease
      • Hashimoto’s Thyroiditis
      • Multiple Sclerosis
      • Multiplex Rheumatoid Arthritis
      • Systemic Lupus Erythematosus (SLE)
      • Type 1 Diabetes
      • Other Autoimmune Diseases
    • Market Value Forecast, by Test Type, 2021-2036
      • Antinuclear Antibody (ANA) Tests
      • Rheumatoid Factor (RF) Tests
      • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests
      • Autoantibody Tests
      • C-reactive Protein (CRP) Tests
      • Erythrocyte Sedimentation Rate (ESR) Tests
      • Complete Blood Count (CBC)
      • Comprehensive Metabolic Panel
      • Urinalysis
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Market Attractiveness Analysis
      • By Product Type
      • By Disease Type
      • By Test Type
      • By End-user
  39. Competition Landscape
    • Market Player - Competition Matrix (By Tier and Size of Companies)
    • Market Share Analysis, by Company (2025)
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Siemens Healthineers AG
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Danaher Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • bioMérieux SA
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Beckman Coulter, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Grifols, S.A.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Hologic, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Ortho Clinical Diagnostics Holdings plc
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • QuidelOrtho Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Trinity Biotech plc
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Sekisui Diagnostics, LLC
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Omega Diagnostics Group PLC
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • AESKU.GROUP GmbH & Co. KG
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • EUROIMMUN Medizinische Labordiagnostika AG
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Inova Diagnostics, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Werfen (Instrumentation Laboratory Company)
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Quest Diagnostics Incorporated
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments

List of Tables

Table 01: Global Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 02: Global Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 03: Global Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 04: Global Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 05: Global Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 06: North America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 07: North America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 08: North America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 09: North America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 10: North America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 11: U.S. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 12: U.S. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 13: U.S. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 14: U.S. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 15: Canada Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 16: Canada Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 17: Canada Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 18: Canada Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 19: Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 20: Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 21: Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 22: Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 23: Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 24: Germany Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 25: Germany Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 26: Germany Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 27: Germany Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 28: U.K. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 29: U.K. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 30: U.K. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 31: U.K. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 32: France Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 33: France Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 34: France Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 35: France Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 36: Italy Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 37: Italy Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 38: Italy Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 39: Italy Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 40: Spain Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 41: Spain Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 42: Spain Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 43: Spain Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 44: The Netherlands Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 45: The Netherlands Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 46: The Netherlands Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 47: The Netherlands Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 48: Rest of Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 49: Rest of Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 50: Rest of Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 51: Rest of Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 52: Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 53: Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 54: Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 55: Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 56: Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 57: China Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 58: China Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 59: China Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 60: China Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 61: Japan Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 62: Japan Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 63: Japan Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 64: Japan Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 65: India Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 66: India Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 67: India Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 68: India Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 69: South Korea Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 70: South Korea Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 71: South Korea Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 72: South Korea Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 73: Australia Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 74: Australia Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 75: Australia Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 76: Australia Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 77: ASEAN Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 78: ASEAN Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 79: ASEAN Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 80: ASEAN Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 81: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 82: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 83: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 84: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 85: Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 86: Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 87: Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 88: Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 89: Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 90: Brazil Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 91: Brazil Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 92: Brazil Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 93: Brazil Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 94: Mexico Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 95: Mexico Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 96: Mexico Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 97: Mexico Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 98: Argentina Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 99: Argentina Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 100: Argentina Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 101: Argentina Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 102: Rest of Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 103: Rest of Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 104: Rest of Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 105: Rest of Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 106: Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 107: Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 108: Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 109: Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 110: Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 111: GCC Countries Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 112: GCC Countries Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 113: GCC Countries Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 114: GCC Countries Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 115: South Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 116: South Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 117: South Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 118: South Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 119: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Product Type, 2021 to 2036
Table 120: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 121: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by Test Type, 2021 to 2036
Table 122: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, by End-user, 2021 to 2036

List of Figures

Figure 01: Global Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 02: Global Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 03: Global Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 04: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Consumables & Assays (Reagents & Kits), 2021 to 2036
Figure 05: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Instruments, 2021 to 2036
Figure 06: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Software & Services, 2021 to 2036
Figure 07: Global Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 08: Global Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 09: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Graves’ Disease, 2021 to 2036
Figure 10: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Hashimoto’s Thyroiditis, 2021 to 2036
Figure 11: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Multiple Sclerosis, 2021 to 2036
Figure 12: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Rheumatoid Arthritis, 2021 to 2036
Figure 13: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Systemic Lupus Erythematosus (SLE), 2021 to 2036
Figure 14: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Type 1 Diabetes, 2021 to 2036
Figure 15: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Other Autoimmune Diseases, 2021 to 2036
Figure 16: Global Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 17: Global Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 18: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Antinuclear Antibody (ANA) Tests, 2021 to 2036
Figure 19: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Rheumatoid Factor (RF) Tests, 2021 to 2036
Figure 20: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Anti-Cyclic Citrullinated Peptide (Anti-CCP) Tests, 2021 to 2036
Figure 21: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Autoantibody Tests, 2021 to 2036
Figure 22: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by C-reactive Protein (CRP) Tests, 2021 to 2036
Figure 23: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Erythrocyte Sedimentation Rate (ESR) Tests, 2021 to 2036
Figure 24: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Complete Blood Count (CBC), 2021 to 2036
Figure 25: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Comprehensive Metabolic Panel, 2021 to 2036
Figure 26: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Urinalysis, 2021 to 2036
Figure 27: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Other Diagnostic Tests, 2021 to 2036
Figure 28: Global Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 29: Global Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 30: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Hospitals, 2021 to 2036
Figure 31: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Diagnostic Laboratories, 2021 to 2036
Figure 32: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Academic & Research Institutes, 2021 to 2036
Figure 33: Global Autoimmune Disease Diagnostics Market Revenue (USD Billion), by Others, 2021 to 2036
Figure 34: Global Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 35: Global Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 36: North America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 37: North America Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 38: North America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 39: North America Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 40: North America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 41: North America Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 42: North America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 43: North America Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 44: North America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 45: North America Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 46: North America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 47: U.S. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 48: U.S. Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 49: U.S. Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 50: U.S. Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 51: U.S. Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 52: U.S. Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 53: U.S. Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 54: U.S. Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 55: U.S. Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 56: Canada Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 57: Canada Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 58: Canada Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 59: Canada Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 60: Canada Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 61: Canada Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 62: Canada Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 63: Canada Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 64: Canada Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 65: Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 66: Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 67: Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 68: Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 69: Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 70: Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 71: Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 72: Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 73: Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 74: Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 75: Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 76: Germany Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 77: Germany Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 78: Germany Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 79: Germany Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 80: Germany Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 81: Germany Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 82: Germany Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 83: Germany Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 84: Germany Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 85: U.K. Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 86: U.K. Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 87: U.K. Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 88: U.K. Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 89: U.K. Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 90: U.K. Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 91: U.K. Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 92: U.K. Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 93: U.K. Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 94: France Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 95: France Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 96: France Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 97: France Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 98: France Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 99: France Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 100: France Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 101: France Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 102: France Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 103: Italy Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 104: Italy Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 105: Italy Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 106: Italy Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 107: Italy Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 108: Italy Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 109: Italy Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 110: Italy Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 111: Italy Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 112: Spain Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 113: Spain Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 114: Spain Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 115: Spain Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 116: Spain Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 117: Spain Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 118: Spain Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 119: Spain Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 120: Spain Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 121: The Netherlands Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 122: The Netherlands Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 123: The Netherlands Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 124: The Netherlands Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 125: The Netherlands Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 126: The Netherlands Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 127: The Netherlands Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 128: The Netherlands Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 129: The Netherlands Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 130: Rest of Europe Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 131: Rest of Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 132: Rest of Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 133: Rest of Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 134: Rest of Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 135: Rest of Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 136: Rest of Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 137: Rest of Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 138: Rest of Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 139: Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 140: Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 141: Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 142: Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 143: Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 144: Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 145: Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 146: Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 147: Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 148: Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 149: Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 150: China Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 151: China Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 152: China Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 153: China Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 154: China Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 155: China Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 156: China Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 157: China Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 158: China Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 159: Japan Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 160: Japan Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 161: Japan Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 162: Japan Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 163: Japan Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 164: Japan Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 165: Japan Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 166: Japan Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 167: Japan Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 168: India Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 169: India Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 170: India Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 171: India Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 172: India Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 173: India Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 174: India Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 175: India Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 176: India Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 177: South Korea Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 178: South Korea Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 179: South Korea Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 180: South Korea Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 181: South Korea Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 182: South Korea Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 183: South Korea Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 184: South Korea Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 185: South Korea Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 186: Australia Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 187: Australia Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 188: Australia Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 189: Australia Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 190: Australia Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 191: Australia Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 192: Australia Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 193: Australia Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 194: Australia Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 195: ASEAN Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 196: ASEAN Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 197: ASEAN Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 198: ASEAN Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 199: ASEAN Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 200: ASEAN Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 201: ASEAN Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 202: ASEAN Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 203: ASEAN Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 204: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 205: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 206: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 207: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 208: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 209: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 210: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 211: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 212: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 213: Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 214: Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 215: Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 216: Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 217: Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 218: Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 219: Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 220: Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 221: Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 222: Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 223: Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 224: Brazil Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 225: Brazil Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 226: Brazil Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 227: Brazil Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 228: Brazil Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 229: Brazil Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 230: Brazil Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 231: Brazil Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 232: Brazil Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 233: Mexico Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 234: Mexico Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 235: Mexico Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 236: Mexico Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 237: Mexico Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 238: Mexico Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 239: Mexico Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 240: Mexico Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 241: Mexico Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 242: Argentina Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 243: Argentina Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 244: Argentina Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 245: Argentina Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 246: Argentina Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 247: Argentina Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 248: Argentina Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 249: Argentina Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 250: Argentina Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 251: Rest of Latin America Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 252: Rest of Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 253: Rest of Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 254: Rest of Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 255: Rest of Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 256: Rest of Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 257: Rest of Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 258: Rest of Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 259: Rest of Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 260: Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 261: Middle East and Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 262: Middle East and Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 263: Middle East and Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 264: Middle East and Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 265: Middle East and Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 266: Middle East and Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 267: Middle East and Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 268: Middle East and Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 269: Middle East and Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 270: Middle East and Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 271: GCC Countries Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 272: GCC Countries Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 273: GCC Countries Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 274: GCC Countries Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 275: GCC Countries Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 276: GCC Countries Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 277: GCC Countries Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 278: GCC Countries Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 279: GCC Countries Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 280: South Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 281: South Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 282: South Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 283: South Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 284: South Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 285: South Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 286: South Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 287: South Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 288: South Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 289: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 290: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 291: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 292: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 293: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 294: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2025 and 2036
Figure 295: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 296: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 297: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036

Copyright © Transparency Market Research, Inc. All Rights reserved

Autoimmune Disease Diagnostics Market

Buy This ReportBuy Now